Dr. Lynch most recently served as chief scientific officer at New York City-based pharmaceutical manufacturer Bristol-Myers Squibb.
While at Bristol-Myers Squibb, he focused on cancer, cardiovascular disease, fibrosis and immunoscience research and development efforts, including translational immuno-oncology research, according to a news release.
Dr. Lynch’s previous positions include chairman and CEO of Massachusetts General Physicians Organization, a multispecialty medical group; director of Yale Cancer Center; physician-in-chief of Yale’s Smilow Cancer Hospital in New Haven, Conn.; professor of medicine at Yale School of Medicine; chief of hematology-oncology at Boston-based Massachusetts General Hospital; and professor of medicine at Harvard Medical School.
More articles on executive moves:
AdventHealth taps Justin Birmele to helm Winter Park hospital
Cape Fear Valley Health System CEO Mike Nagowski returns from medical leave
Joseph Mullany named president of Vassar Brothers Medical Center
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.